Package Insert: Information for the User
Sertraline Qualigen Farma 100 mg Film-Coated Tablets
Read this package insert carefully before starting to take this medication, as it contains important information for youthismedication, because it contains important information for you.
Sertralina Qualigen Farma contains sertraline as the active ingredient. Sertraline belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs); these
medicines are used to treat depression and/or anxiety disorders.
Sertralina Qualigen Farma can be used to treat:
Depression is a clinical disease with symptoms such as feelings of sadness, inability to sleep well or to enjoy life as one used to.
OCD and anxiety disorders are anxiety-related diseases, with symptoms such as being constantly preoccupied with repeated ideas (obsessions) that lead to repetitive rituals (compulsions).
PTSD is a disorder that may occur after a very emotionally traumatic experience, and has some symptoms similar to depression and anxiety. Social anxiety disorder (social phobia) is an anxiety-related disease. It is characterized by intense anxiety or anguish in social situations (for example: speaking to strangers, speaking in public, eating or drinking in front of others, or worrying about behaving in a shameful manner).
Your doctor has considered that this medicine is suitable for treating your condition.
If you are unsure why you have been prescribed Sertralina Qualigen Farma, you should consult your doctor.
Do not take Sertralina Qualigen Farma:
Do not take Sertralina Qualigen Farma if you are taking another medication called pimozide (a medication used to treat mental disorders such as psychosis).
Consult your doctor or pharmacist before starting to take Sertralina Qualigen Farma.
Medicines are not always suitable for everyone. Before starting treatment with Sertralina Qualigen Farma, tell your doctor if you have or have had any of the following conditions:
Restlessness/Acatisia:
The use of sertraline has been associated with unpleasant restlessness and a need to move, often accompanied by an inability to sit or stand still (acatisia). This occurs more often during the first few weeks of treatment. Increasing the dose may be harmful, so if you develop these symptoms, you should contact your doctor.
Withdrawal symptoms:
Side effects related to stopping treatment (withdrawal symptoms) are common, particularly if treatment is stopped abruptly (see section 3. If you stop taking sertraline and section 4. Possible side effects). The risk of withdrawal symptoms depends on the duration of treatment, the dose, and the rate at which the dose is reduced. Generally, these symptoms are mild or moderate. However, in some patients, they can be severe. These symptoms usually occur during the first few days after stopping treatment. In general, these symptoms usually resolve on their own and usually resolve within two weeks. In some patients, they may last longer (2-3 months or more). It is recommended that when stopping treatment with sertraline, the dose be gradually reduced over a period of several weeks or even months, and you should always agree with your doctor on the best way to stop treatment.
Thoughts of suicide and worsening of depression or anxiety disorder:
If you are depressed and/or have anxiety disorders, you may have thoughts of harming yourself or committing suicide. This may increase at the beginning of treatment with antidepressants, as all these medications take time to take effect, which is usually two weeks but can be longer.
This is more likely to happen:
If you have thoughts of harming yourself or committing suicide at any time, contact your doctor or go to the hospital immediately.
It may be helpful for you to explain to a close family member or friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.
Some medications in the group to which sertraline belongs (called SSRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Normally, sertraline should not be used to treat children and adolescents under 18 years old, except in the case of patients with obsessive-compulsive disorder (OCD). Young patients have a higher risk of side effects such as suicidal thoughts, self-harm, or suicidal behavior (suicidal ideation) and hostility (predominantly aggression, confrontational behavior, and irritable reaction) when treated with this class of medications. However, your doctor may decide to prescribe Sertralina Qualigen Farma to a patient under 18 years old if they consider it to be the most suitable option for the patient. If your doctor has prescribed this medication and you are under 18 years old and want to discuss this decision, please return to your doctor. You should inform your doctor if any of the symptoms listed above appear or worsen while you are taking sertraline.
At the same time, the long-term effects on safety and related to growth, maturity, and learning (cognitive development) and behavioral development of sertraline in this age group have not yet been demonstrated.
Other medications and Sertralina Qualigen Farma:
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Some medications may affect how this medication works, or this medication itself may reduce the effectiveness of other medications you are taking at the same time.
The use of Sertralina Qualigen Farma with the following medications may cause severe side effects:
Inform your doctor if you are taking the following medications:
Taking Sertralina Qualigen Farma with food, drinks, and alcohol:
You can take this medication with or without food.
Avoid drinking alcohol while taking sertraline.
Do not take sertraline with grapefruit juice, as it may increase the levels of sertraline in your body.
Pregnancy, breastfeeding, and fertility:
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
The safety of sertraline in pregnant women has not been fully established.
If you are pregnant, sertraline will only be given to you if your doctor considers that the benefits for you outweigh any possible risk to the developing fetus.
If you take sertraline in the final stages of pregnancy, there may be an increased risk of excessive vaginal bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking Sertralina Qualigen Farma so that they can advise you.
When taken during pregnancy, especially in the last three months, medications like sertraline may increase the risk of a serious condition in newborns called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and appear blue. These symptoms usually start within the first 24 hours after birth. If this happens to your baby, contact your midwife and/or doctor immediately.
Your newborn baby may have other conditions, which usually manifest within the first 24 hours after birth. The symptoms include:
• difficulty breathing,
• blue skin or too hot or cold,
• blue lips,
• vomiting or feeding problems,
• excessive tiredness, unable to sleep, or crying a lot,
• muscle stiffness or decreased muscle tone,
• tremors, restlessness, or convulsions,
• increased reflexes,
• irritability,
• low blood sugar.
If your baby has any of these symptoms at birth, or you are concerned about your baby's health, consult your doctor or midwife for advice.
Sertraline may pass into breast milk. Therefore, sertraline can only be used in women who are breastfeeding if your doctor considers that the benefits outweigh any possible risk to the baby.
Studies in animals have shown that some medications, such as sertraline, may reduce the quality of sperm. Theoretically, this could affect fertility, but the impact on human fertility has not yet been determined.
Driving and operating machinery:
Sertralina Qualigen Farma contains lactose and sodium:
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist.
Sertralina Qualigen Farma can be taken with or without food.
Take your medication once a day in the morning or evening.
Consult your doctor or pharmacist again if you are unsure.
The recommended dose is:
Adults:
Depression and Obsessive-Compulsive Disorder:
The commonly effective dose for depression and OCD is 50 mg per day. The daily dose can be increased by 50 mg at intervals of at least one week, and thus over several weeks. The maximum recommended daily dose is 200 mg.
Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder:
For anxiety disorder, social anxiety disorder, and post-traumatic stress disorder, treatment should begin with a dose of 25 mg per day, and increased to 50 mg per day after one week.
The daily dose can be increased at intervals of 50 mg over a period of several weeks. The maximum recommended daily dose is 200 mg.
Use in children and adolescents:
Sertralina Qualigen Farma should only be used to treat children and adolescents aged 6 to 17 years with OCD.
Obsessive-Compulsive Disorder:
Children aged 6 to 12 years: The recommended starting dose is 25 mg per day. After one week, your doctor may increase the dose to 50 mg per day. The maximum dose is 200 mg per day.
Adolescents aged 13 to 17 years: The recommended starting dose is 50 mg per day. The maximum dose is 200 mg per day.
If you have liver or kidney problems, inform your doctor and follow their instructions.
Administration form:
Your doctor will indicate the duration of treatment with this medication. The duration will depend on the nature of your illness and your response to treatment. It may take several weeks for your symptoms to improve.
If you take more Sertralina Qualigen Farma than you should
If you accidentally take an excessive amount of sertralina, contact your doctor or go to the nearest hospital emergency department. Always carry the medication packaging with you, whether it contains medication or not.
You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
The symptoms of overdose may include drowsiness, nausea, and vomiting, rapid heart rate, tremors, agitation, dizziness, and in rare cases, unconsciousness.
If you forget to take Sertralina Qualigen Farma
Do not take a double dose to compensate for the missed doses. If you forget to take a dose, do not take it when you remember. Take the next dose when it is due.
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Sertralina Qualigen Farma
Do not interrupt treatment with Sertralina Qualigen Farma unless your doctor tells you to. Your doctor will want to gradually reduce the dose of this medication over several weeks before stopping it completely. If you stop treatment abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors. If you experience any of these adverse effects, or any other during the interruption of your treatment with sertralina, please inform your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The most common side effect is nausea. Side effects depend on the dose and often disappear or decrease as treatment continues.
Inform your doctor immediately
If you experience any of the following symptoms after taking this medicine, as these symptoms can be serious.
The following side effects were observed in clinical trials in adults and after marketing.
Very common (may affect more than 1 in 10 patients):
Common (may affect up to 1 in 10 patients):
Uncommon (may affect up to 1 in 100 patients)::
Rare (may affect up to 1 in 1,000 patients):
Frequency not known (cannot be estimated from available data):
*Adverse effects reported after marketing.
Other adverse effects in children and adolescents
In clinical trials in children and adolescents, adverse effects were generally similar to those reported in adults (see above). The most common adverse effects in children and adolescents were headache, insomnia, diarrhea, and nausea.
Symptoms that may appear when treatment is stopped
If you stop treatment with this medicine abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors (see section 3. If you stop treatment with Sertralina Qualigen Farma).
A higher risk of bone fractures has been observed in patients taking this type of medication.
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging, after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask.your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
at your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Sertralina Qualigen Farma
Appearance of the product and content of the packaging
Sertralina Qualigen Farma is presented in coated tablets with a white or light gray film.
Sertralina Qualigen Farma is available in three packaging sizes: 30, 60, and 500 tablets. The tablets are presented in aluminum/PVC-PVDC blisters.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Neuraxpharm Spain, S.L.U.
Ave. Barcelona, 69
08970- Sant Joan Despí
Barcelona – Spain
Responsible for manufacturing:
Laboratorios Cinfa, S.A.
Olaz-Chipi, 10, Industrial Estate Areta
(Huarte-Pamplona) – 31620
Spain
O
Toll Manufacturing Services, S.L.
Aragoneses 2, 28108 Alcobendas
Madrid – Spain
Last review date of this leaflet: July 2022
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.